首页> 美国卫生研究院文献>Cancer Science >Tumor necrosis factor‐α induces prostate cancer cell migration in lymphatic metastasis through CCR7 upregulation
【2h】

Tumor necrosis factor‐α induces prostate cancer cell migration in lymphatic metastasis through CCR7 upregulation

机译:肿瘤坏死因子-α通过CCR7上调诱导前列腺癌淋巴转移中的细胞迁移

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Understanding the mechanism of lymph node metastasis, a poor prognostic sign for prostate cancer, and the further dissemination of the disease is important to develop novel treatment strategies. Recent studies have reported that C‐C chemokine receptor 7 (CCR7), whose ligand is CCL21, is abundantly expressed in lymph node metastasis and promotes cancer progression. Tumor necrosis factor‐α (TNF‐α) is chronically produced at low levels within the tumor microenvironment. The aim of this study was to determine whether TNF‐α promotes prostate cancer dissemination from metastatic lymph nodes through activation of the CCL21/CCR7 axis. First, human prostate cancer cells were determined to express both TNF‐α and CCR7. Second, low concentrations of TNF‐α were confirmed to induce CCR7 in prostate cancer cells through phosphorylation of ERK. Finally, CCL21 was found to promote the migration of prostate cancer cells through phosphorylation of the protein kinase p38. Our results suggest that TNF‐α leads to the induction of CCR7 expression and that the CCL21/CCR7 axis might increase the metastatic potential of prostate cancer cells in lymph node metastasis.
机译:了解淋巴结转移的机制,前列腺癌的不良预后体征以及进一步传播该疾病对于开发新的治疗策略很重要。最近的研究报道,配体为CCL21的C‐C趋化因子受体7(CCR7)在淋巴结转移中大量表达并促进癌症进展。肿瘤坏死因子-α(TNF-α)在肿瘤微环境中长期低水平产生。这项研究的目的是确定TNF-α是否通过激活CCL21 / CCR7轴来促进前列腺癌从转移性淋巴结扩散。首先,确定人类前列腺癌细胞同时表达TNF-α和CCR7。其次,证实低浓度的TNF-α通过ERK的磷酸化在前列腺癌细胞中诱导CCR7。最后,发现CCL21通过蛋白激酶p38的磷酸化促进前列腺癌细胞的迁移。我们的结果表明,TNF-α导致CCR7表达的诱导,而CCL21 / CCR7轴可能增加前列腺癌细胞在淋巴结转移中的转移潜能。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号